CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This randomized phase II trial studies how well carboplatin with or without atezolizumab works in treating patients with stage IV triple negative...
Phase 2
Nashville, Tennessee, United States and 5 other locations
The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...
Phase 2
Nashville, Tennessee, United States and 8 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Nashville, Tennessee, United States and 23 other locations
avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...
Phase 2
Nashville, Tennessee, United States and 11 other locations
This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...
Phase 1
Nashville, Tennessee, United States and 17 other locations
the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple...
Phase 3
Nashville, Tennessee, United States and 135 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Nashville, Tennessee, United States and 228 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Nashville, Tennessee, United States and 508 other locations
the RP2D. The RP2D will be administered to 3 cohorts of patients in the Dose Expansion Phase.* Cohort A: Advanced or Metastatic Triple Negative...
Phase 1, Phase 2
Nashville, Tennessee, United States and 15 other locations
AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 ef...
Phase 1
Nashville, Tennessee, United States and 1 other location
Clinical trials
Research sites
Resources
Legal